相关实验视频
Updated: May 2, 2026
07:45
Retroductal Nanoparticle Injection to the Murine Submandibular Gland
Published on: May 3, 2018
10.7K
一种对衰老有反应的纳米药物放大了放射治疗的疗效
Yu Hua1, Hua Song2, Hongpei Deng1
1Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Road, Shanghai 200011, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Lane. 833 Zhizaoju Road, Shanghai 200011, China.
概括
这项研究介绍了Lipo@ABT263@Au,这是一种新的纳米药物,其向衰老细胞,以增强癌症放射治疗. 这种方法提高了瘤治疗的有效性,并减少了皮肤纤维化等副作用.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 放射治疗 (RT) 是一种主要的癌症治疗方法,但其有效性受到瘤耐药性和健康组织损伤的阻碍.
- 疗法诱导的细胞衰老是放射治疗中对抗性和非目标损伤的重要因素.
研究的目的:
- 开发一种新型纳米药物,Lipo@ABT263@Au,将老化剂与金脂质体结合起来.
- 研究这种纳米药物克服放射治疗耐药性和减轻相关毒性的潜力.
主要方法:
- 高通量选和转录基因分析以确定RT诱导的漏洞.
- 在癌症模型中使用Lipo@ABT263@Au纳米药物的体外和体内研究.
- 评估纳米药物在消除衰老细胞,增强细胞亡和抑制衰老相关分泌表型 (SASP) 的有效性.
主要成果:
- 在体外和体内,Lipo@ABT263@Au有效地消除了衰老的瘤细胞和纤维细胞.
- 该纳米药物增强了放射治疗诱导的亡,并抑制了亲瘤原生的SASP效应.
- 在体内,该纳米药物证明了有效的瘤积累,显著的瘤生长抑制和缓解RT诱导的皮肤纤维化,没有系统性毒性.
结论:
- Lipo@ABT263@Au代表了癌症放射治疗的有前途的"一两拳"策略.
- 这种纳米药物平台有效地向衰老细胞,增强治疗结果并减少副作用.
- 这些发现表明,通过改进的放射治疗策略来推进癌症治疗的临床相关性.
相关概念视频
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400